KEYNOTE-590 Study: 5-Year Results of Pembrolizumab Plus Chemo in First-Line Esophageal Cancer: Gastrointestinal 6 Mins Read7 OncologyTube: Okay, we’re here at ASCO GI 2024. We have Dr. Manish Shah, medical doctor, and the director of gastrointestinal…
